Thu, 13 May 2021 12:09:42: NEA-backed Allay exits stealth with clinical pain data, plans to reduce need for opioids

Thu, 13 May 2021 11:33:41: Autolus' CD19 CAR-T posts 100% complete response rate, zero grade 3 CRS in small lymphoma trial

Thu, 13 May 2021 11:26:23: How a genetic 'CopyCatcher' could open the door to CRISPR-based precision gene therapy

Wed, 12 May 2021 13:02:58: Biogen buys midphase drug to challenge Roche for stroke market

Wed, 12 May 2021 12:47:31: Alexion founder Squinto helms OrbiMed-backed startup with some Yale gene therapy tech

Wed, 12 May 2021 12:12:51: As data near, U.K. rethinks AstraZeneca COVID-19 antibody deal

Wed, 12 May 2021 09:05:09: Call for your Fierce Biotech Fierce 15 nominations for 2021

Tue, 11 May 2021 18:00:31: Amgen, AstraZeneca's tezepelumab is looking for a slice of blockbuster asthma market dominated by Sanofi's Dupixent

Tue, 11 May 2021 11:59:10: Ginkgo lands on NYSE via $17.5B SPAC merger, giving it billions to fuel growth 

Tue, 11 May 2021 08:34:38: Nuvalent bags $135M to trial resistance-beating kinase inhibitors in lung cancer

Tue, 11 May 2021 06:19:13: Lilly, MiNA ink broad deal to upregulate proteins using RNA

Mon, 10 May 2021 18:39:17: COVID-flu combo vaccine from Novavax sparks immune response to both viruses in animals

Mon, 10 May 2021 14:25:36: Attacking aging and chronic disease by eliminating 'senescent' cells with immunotherapy

Mon, 10 May 2021 12:20:16: Bayer's near-approval Farxiga rival meets goal in 2nd phase 3

Mon, 10 May 2021 01:02:59: Flagship debuts Laronde to develop RNA-based meds that could turn cells into protein factories

Fri, 07 May 2021 14:17:38: Daiichi Sankyo, AstraZeneca's $5B Enhertu follow-up shows early signs of success in breast cancer

Fri, 07 May 2021 13:50:22: Gene therapy biotech Gyroscope finds unnavigable seas on IPO market

Fri, 07 May 2021 10:49:22: Adcomm experts split on whether to approve ChemoCentryx's avacopan

Fri, 07 May 2021 10:07:57: Galapagos cuts pipeline, targets €150M in savings after setbacks

Fri, 07 May 2021 08:15:38: Science 37 taps a SPAC to go public, with siteless trial specialist valued at a cool $1B

Fri, 07 May 2021 08:02:31: CRISPR therapeutics, Nkarta pen new cutting-edge cancer tech research pact

Thu, 06 May 2021 21:21:13: Chutes & Ladders—Former Merck R&D chief Perlmutter takes reins at Eikon, applying Nobel-winning tech to drug discovery

Thu, 06 May 2021 12:49:53: Merck takes $170M charge on abandoned COVID-19 drug

Thu, 06 May 2021 12:11:08: Bluebird names oncology spinoff, establishes leadership team

Thu, 06 May 2021 10:08:28: A cancer vaccine built from stem cells? Stanford candidate shows promise in pancreatic tumors